Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz
Public ClinicalTrials.gov record NCT06240455. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Placebo-controlled, Phase 2 Dose-range Study to Assess the Efficacy and Safety of WP1302 in Preventing Disease Relapse Following Methimazole Withdrawal in Subjects With Graves' Disease
Study identification
- NCT ID
- NCT06240455
- Recruitment status
- Suspended
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Worg Biotherapeutics Inc.
- Other
- Enrollment
- 176 participants
Conditions and interventions
Conditions
Interventions
- WP1302 Drug
- WP1302 placebo Drug
- methimazole Combination Product
Drug · Combination Product
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 30, 2026
- Primary completion
- Mar 30, 2029
- Completion
- Sep 29, 2030
- Last update posted
- May 7, 2025
2026 – 2030
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| East Valley Diabetes and Endocrinology-Clinical Research, PLLC | Hunt | Arizona | 85143 | — |
| Alliance Research Institute | Canoga Park | California | 22110 | — |
| Paradigm Clinical Research Centers - Littleton | Littleton | Colorado | 80120 | — |
| BayCare Health System, Inc. | Clearwater | Florida | 33759 | — |
| Albuquerque Clinical Trials Inc | Albuquerque | New Mexico | 87102 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Clinical Research Solution LLC dba Endocrine and Psychiatry Center | Houston | Texas | 77095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06240455, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2025 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06240455 live on ClinicalTrials.gov.